Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Vaccine

• Publication date

  2013-08-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2013.05.107PMID 23770306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of Immunopotentiation and Safety of Aluminum Adjuvants

  2013cited by this paper
• A Critical Analysis of Rejection in Vascularized Composite Allotransplantation: Clinical, Cellular and Molecular Aspects, Current Challenges, and Novel Concepts

  2013cited by this paper
• ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation

  2012cited by this paper
• Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 Responses

  2012cited by this paper
• Suppression of Vaccine Immunity by Inflammatory Monocytes

  2012cited by this paper
• Neutrophils cascading their way to inflammation.

  2011cited by this paper
• Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

  2011cited by this paper
• DNA released from dying host cells mediates aluminum adjuvant activity

  2011cited by this paper
• Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair

  2011cited by this paper
• Unmet needs in modern vaccinology: adjuvants to improve the immune response.

  2010cited by this paper
• Phagocyte partnership during the onset and resolution of inflammation

  2010cited by this paper
• The sterile inflammatory response.

  2010cited by this paper
• T‐helper 1 and T‐helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection

  2010cited by this paper
• Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.

  2010cited by this paper
• Vaccine adjuvants: putting innate immunity to work.

  2010cited by this paper
• The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant.

  2010cited by this paper
• Neutrophils Influence the Level of Antigen Presentation during the Immune Response to Protein Antigens in Adjuvants

  2010cited by this paper
• Towards an understanding of the adjuvant action of aluminium

  2009cited by this paper
• Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity1

  2009cited by this paper
• Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

  2008cited by this paper
• The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells1

  2008cited by this paper
• Chemokine Profile of Different Inflammatory Myopathies Reflects Humoral versus Cytotoxic Immune Responses

  2007cited by this paper
• Expression of chitinase‐like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice

  2006cited by this paper
• The eosinophil.

  2006cited by this paper
• The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia1

  2005cited by this paper
• Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.

  2004cited by this paper
• Aluminium compounds for use in vaccines

  2004cited by this paper
• Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.

  2003cited by this paper
• Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

  2003cited by this paper
• A simple method for the in situ detection of eosinophils.

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• The neutrophil as a cellular source of chemokines

  2000cited by this paper
• C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (mono

  1999cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Predicting the adsorption of proteins by aluminium-containing adjuvants.

  1991cited by this paper
• Thy-1 antigen-bearing dendritic cells in murine epidermis are derived from bone marrow precursors.

  1984cited by this paper
• Conjugated avidin identifies cutaneous rodent and human mast cells.

  1984cited by this paper
• Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid

  1982cited by this paper
• Surface properties of bacillus Calmette-Guerin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia

  1981cited by this paper
• Eosinophil Response to Alum Adjuvants: Involvement of T Cells in Non-Antigen-Dependent Mechanisms 1

  1977cited by this paper
• Granuloma induction in the peritoneal cavity. A model for the study of inflammation and plasmacytopoiesis in nonlymphatic organs.

  1972cited by this paper
• Journal of Immune Based Therapies and Vaccines an Alternative Approach to Combination Vaccines: Intradermal Administration of Isolated Components for Control of Anthrax, Botulism, Plague and Staphylococcal Toxic Shock

  year unknowncited by this paper

• Impact of adjuvants on innate and adaptive immune responses to Lawsonia intracellularis antigens in pigs when administered via the intradermal route.

  2026cites this paper
• USE OF NANOPARTICLES AND NANOMATERIALS TO INCREASE THE EFFICACY OF VACCINE PREPARATIONS

  2025cites this paper
• Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations

  2025cites this paper
• An Evaluation of the Safety, Immunogenicity, and Protective Efficacy of a Combined Diphtheria–Tetanus–Acellular Pertussis, Haemophilus influenzae Type b, and ACYW135 Meningococcal Conjugate Vaccine in Murine and Rat Models

  2025cites this paper
• Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma

  2025cites this paper
• Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway

  2024cites this paper
• Re-inventing traditional aluminum-based adjuvants: Insight into a century of advancements

  2024cites this paper
• Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica Nanoparticles.

  2024cites this paper
• Vaccine adjuvants: current status, research and development, licensing, and future opportunities.

  2024cites this paper
• Silk Fibroin-Coated Nano-MOFs Enhance the Thermal Stability and Immunogenicity of HBsAg.

  2024cites this paper
• Morphometry, cellular characterization and temporal evolution of granulomas induced by aluminium oxyhydroxide in sheep.

  2024cites this paper
• Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines.

  2024cites this paper
• Therapeutic potential of monomethyl fumarate and aluminum ion combination in alleviating inflammation and oxidative stress in psoriasis

  2024cites this paper
• Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections

  2024cites this paper
• Adsorption and Desorption of Immune-Modulating Substances by Aluminium-Based Adjuvants: An Overlooked Feature of the Immune-Stimulating Mechanisms of Aluminium-Based Adjuvants

  2024cites this paper
• Modeling the Kinetics of Lymph Node Retention and Exposure of a Cargo Protein Delivered by Biotin-Functionalized Nanoparticles.

  2023cites this paper
• A Comparative Study of the Effects of Al(OH)3 and AlPO4 Adjuvants on the Production of Neutralizing Antibodies (NAbs) against Bovine parainfluenza Virus Type 3 (BPIV3) in Guinea Pigs.

  2023cites this paper
• Advances on the early cellular events occurring upon exposure of human macrophages to aluminum oxyhydroxide adjuvant

  2023cites this paper
• Vaccine Adjuvants Induce Formation of Intraperitoneal Extracellular Traps in Flounder (Paralichthys olivaceus)

  2022cites this paper
• Emerging adjuvants for intradermal vaccination

  2022cites this paper
• An investigation and assessment of the muscle damage and inflammation at injection site of aluminum-adjuvanted vaccines in guinea pigs.

  2022cites this paper
• Early suppression of antiviral host response and protocadherins by SARS-CoV-2 Spike protein in THP-1-derived macrophage-like cells

  2022influential citation
• Clearance, biodistribution, and neuromodulatory effects of aluminum-based adjuvants. Systematic review and meta-analysis: what do we learn from animal studies?

  2022cites this paper
• Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives

  2022cites this paper
• Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats

  2022cites this paper
• Distinct Features of Germinal Center Reactions in Macaques Infected by SIV or Vaccinated with a T-Dependent Model Antigen

  2021cites this paper
• Role of Damage-Associated Molecular Pattern/Cell Death Pathways in Vaccine-Induced Immunity

  2021cites this paper
• Heterologous administration of HPV16 E7 epitope-loaded nanocomplexes inhibits tumor growth in mouse model.

  2021cites this paper
• In vitro approaches for the evaluation of human vaccines

  2021cites this paper
• Targeting Lymphoid Tissues to Promote Immune Tolerance

  2021cites this paper
• In Vitro Characterization of the Innate Immune Pathways Engaged by Live and Inactivated Tick-Borne Encephalitis Virus

  2021cites this paper
• Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination

  2021cites this paper
• Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction

  2021cites this paper
• StreptInCor, a Group A Streptococcal Adsorbed Vaccine: Evaluation of Repeated Intramuscular Dose Toxicity Testing in Rats

  2021cites this paper
• Abated immune responses against recombinant hepatitis-b vaccine by chitin in mice

  2021cites this paper
• The recombinant protein combined vaccine based on the fragment C of tetanus toxin and the cross-reacting material 197

  2021cites this paper
• Metalloimmunology: The metal ion-controlled immunity.

  2020cites this paper
• The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route

  2020cites this paper
• Distinctive cellular response to aluminum based adjuvants

  2020cites this paper
• Controlling timing and location in vaccines

  2020cites this paper
• Lipid Nanoparticle Acts as a Potential Adjuvant for Influenza Split Vaccine without Inducing Inflammatory Responses

  2020cites this paper
• Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential‐dependent NET‐formation

  2020cites this paper
• Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines

  2020cites this paper
• Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses

  2020cites this paper
• The continued advance of vaccine adjuvants - 'we can work it out'.

  2020cites this paper
• Общая характеристика адъювантов и механизм их действия (часть 1)

  2020cites this paper
• General characteristics of adjuvants and their mechanisms of action (part 2)

  2020cites this paper
• Morphology and protein adsorption of aluminum phosphate and aluminum hydroxide and their potential catalytic function in the synthesis of polymeric emulsifiers

  2020influential citation
• Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging

  2019cites this paper
• A comparative study on the mechanisms of innate immune responses in mice induced by Alum and Actinidia eriantha polysaccharide.

  2019cites this paper
• Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats

  2019cites this paper
• Formulation of aluminum hydroxide adjuvant with TLR agonists poly(I:C) and CpG enhances the magnitude and avidity of the humoral immune response.

  2019cites this paper
• Corn-derived alpha-D-glucan nanoparticles as adjuvant for intramuscular and intranasal immunization in pigs.

  2019cites this paper
• Feasibility of Hepatitis B Vaccination by Microneedle Patch: Cellular and Humoral Immunity Studies in Rhesus Macaques.

  2019cites this paper
• Group A Streptococcus Adsorbed Vaccine: Repeated Intramuscular Dose Toxicity Test in Minipigs

  2019cites this paper
• The interaction of aluminium-based adjuvants with THP-1 macrophages in vitro: Implications for cellular survival and systemic translocation.

  2019cites this paper
• Clay Nanoparticles Elicit Long-Term Immune Responses by Forming Biodegradable Depots for Sustained Antigen Stimulation.

  2018cites this paper
• A Guide to IL‐1 family cytokines in adjuvanticity

  2018cites this paper
• Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation?

  2018cites this paper
• Intraperitoneal administration of aluminium‐based adjuvants produces severe transient systemic adverse events in mice

  2018cites this paper
• Intracellular tracing of amyloid vaccines through direct fluorescent labelling

  2018cites this paper
• Tracing Aluminium-based Adjuvants: Their Interactions with Immune Competent Cells and their Effect on Mitochondrial Activity

  2018cites this paper
• Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

  2018cites this paper
• Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.

  2018cites this paper
• Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

  2018cites this paper
• Biomaterials for vaccine‐based cancer immunotherapy

  2018cites this paper
• Adjuvanted influenza vaccines

  2018cites this paper
• Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant

  2017cites this paper
• Sequestering of damage-associated molecular patterns (DAMPs): a possible mechanism affecting the immune-stimulating properties of aluminium adjuvants

  2017cites this paper
• Aluminium Adjuvants – A Nanomaterial used as Adjuvants in Human Vaccines for Decades

  2017cites this paper
• Alpha-D-glucan nanoparticulate adjuvant induces a transient inflammatory response at the injection site and targets antigen to migratory dendritic cells

  2017cites this paper
• Safety and efficiency of active immunization with detoxified antigen against scorpion venom: side effect evaluation

  2017cites this paper
• Dynamics of APC recruitment at the site of injection following injection of vaccine adjuvants.

  2017cites this paper
• Local innate immune responses in the vaccine adjuvant-injected muscle

  2016cites this paper
• Assessment of the Biodistribution of Aluminum-Based Vaccine Adjuvants using 111 / 115 In-AlO ( OH )

  2016influential citation
• Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations

  2016cites this paper
• EVALUATION OF ALPHA-D-GLUCAN NANOPARTICLE AS A VACCINE ADJUVANT

  2016cites this paper
• SQUALENE IMMUNOGENICITY DETERMINATION AS AN ADJUVANT

  2016cites this paper
• Impact of dose, route, and composition on the immunogenicity of immune polyelectrolyte multilayers delivered on gold templates

  2016cites this paper
• The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice

  2016cites this paper
• Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.

  2015cites this paper
• Vaccines, Infections, and Alopecia Areata

  2015cites this paper
• Aluminum Particle Biopersistence, Systemic Transport, and Long‐Term Safety: Macrophagic Myofasciitis and Beyond

  2015cites this paper
• Biopersistence and Brain Translocation of Aluminum Adjuvants of Vaccines

  2015cites this paper
• The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm

  2015influential citation
• Al adjuvants can be tracked in viable cells by lumogallion staining.

  2015cites this paper
• Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes

  2015cites this paper
• Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines

  2015cites this paper
• IL-33 released by alum is responsible for early cytokine production and has adjuvant properties

  2015cites this paper
• Understanding the intracellular regulation of interleukin-1

  2015cites this paper
• Inflammatory responses following intramuscular and subcutaneous immunization with aluminum-adjuvanted or non-adjuvanted vaccines.

  2014cites this paper
• Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8+ T Cell Immunity to a Co-Administered Antigen

  2014cites this paper
• Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line

  2014cites this paper
• Toxinas termo-lábeis (LTs) do tipo II de Escherichia coli enterotoxigênica (ETEC): efeito adjuvante e atividade inflamatória

  2014cites this paper
• A role for impaired regulatory T cell function in adverse responses to aluminum adjuvant-containing vaccines in genetically susceptible individuals.

  2014cites this paper
• Infantile Bullous Pemphigoid Following Hepatitis B Vaccinations

  2014cites this paper
• Random sequential adsorption of trimers and hexamers

  2013cites this paper